### Variants with Similar Effects to rs796053166

The rs796053166 variant is located in the **SCN2A** gene, which encodes a voltage-gated sodium channel subunit. Variants in this gene are often associated with neurological disorders, including **developmental and epileptic encephalopathy (DEE)** and **benign familial infantile seizures (BFIS)**. Below is a detailed analysis of variants at the same genomic position (chr2:165389450) with different alternate alleles (A, G, T) and their effects.

---

### 1. Variant: C>A (rs796053166)
- **HGVS Notation**: 
  - Genomic: `chr2:g.165389450C>A`
  - Transcript: `NM_001040142.2:c.5644C>A`
  - Protein: `NP_001035232.1:p.Arg1882=`
- **Gene**: SCN2A
- **Effect**: Synonymous variant (no change in amino acid sequence).
- **Disease Association**: 
  - **Likely Benign (LB)** for **Developmental and Epileptic Encephalopathy, 11 (DEE11)** and **Benign Familial Infantile Seizures, 3 (BFIS3)**.
- **Allele Frequency**: 
  - Global: 6.16e-06 (gnomAD Exomes).
- **TogoVar Link**: [TogoVar rs796053166](https://togovar.org/variant/2-165389450-C-A)

---

### 2. Variant: C>G (rs796053166)
- **HGVS Notation**: 
  - Genomic: `chr2:g.165389450C>G`
  - Transcript: `NM_001040142.2:c.5644C>G`
  - Protein: `NP_001035232.1:p.Arg1882Gly`
- **Gene**: SCN2A
- **Effect**: Missense variant (Arginine to Glycine substitution at position 1882).
- **Disease Association**: 
  - **Pathogenic (P)** for **DEE11**, **BFIS3**, and **Episodic Ataxia, Type 9**.
  - **Not Provided (NP)** for **Complex Neurodevelopmental Disorder**.
- **Predictive Models**:
  - **SIFT**: 0.0 (deleterious).
  - **AlphaMissense**: 0.8635 (likely pathogenic).
- **Allele Frequency**: Not reported in gnomAD.
- **TogoVar Link**: [TogoVar rs796053166](https://togovar.org/variant/2-165389450-C-G)

---

### 3. Variant: C>T (rs796053166)
- **HGVS Notation**: 
  - Genomic: `chr2:g.165389450C>T`
  - Transcript: `NM_001040142.2:c.5644C>T`
  - Protein: `NP_001035232.1:p.Arg1882Ter`
- **Gene**: SCN2A
- **Effect**: Nonsense variant (introduces a premature stop codon, leading to truncated protein).
- **Disease Association**: 
  - **Pathogenic (P)** for **DEE11**.
  - **Likely Pathogenic (LP)** for **Inborn Genetic Diseases**.
- **Allele Frequency**: Not reported in gnomAD.
- **TogoVar Link**: [TogoVar rs796053166](https://togovar.org/variant/2-165389450-C-T)

---

### Summary of Similar Effects
- **C>A**: Synonymous variant, likely benign.
- **C>G**: Missense variant, pathogenic, associated with multiple neurological disorders.
- **C>T**: Nonsense variant, pathogenic, associated with severe developmental disorders.

These variants demonstrate a spectrum of effects, from benign to pathogenic, depending on the type of nucleotide change and its impact on the SCN2A protein.

---

### Additional Notes
- Variants in **SCN2A** are highly relevant in the context of neurological disorders, particularly epilepsy and neurodevelopmental conditions.
- The **C>G** and **C>T** variants are of particular clinical significance due to their pathogenic nature, while the **C>A** variant is likely benign.

---

### References
- TogoVar: [https://togovar.org](https://togovar.org)
- ClinVar: [VCV002116983](https://www.ncbi.nlm.nih.gov/clinvar/variation/2116983), [VCV000207028](https://www.ncbi.nlm.nih.gov/clinvar/variation/207028), [VCV000450533](https://www.ncbi.nlm.nih.gov/clinvar/variation/450533)

---

### 日本語での説明

#### 1. 変異: C>A (rs796053166)
- **HGVS表記**: 
  - ゲノム: `chr2:g.165389450C>A`
  - トランスクリプト: `NM_001040142.2:c.5644C>A`
  - タンパク質: `NP_001035232.1:p.Arg1882=`
- **遺伝子**: SCN2A
- **影響**: 同義変異（アミノ酸配列に変化なし）。
- **疾患関連**: 
  - **ほぼ良性 (LB)**: **発達性およびてんかん性脳症11型 (DEE11)**、**良性家族性乳児けいれん3型 (BFIS3)**。
- **対立遺伝子頻度**: 
  - グローバル: 6.16e-06 (gnomAD Exomes)。
- **TogoVarリンク**: [TogoVar rs796053166](https://togovar.org/variant/2-165389450-C-A)

---

#### 2. 変異: C>G (rs796053166)
- **HGVS表記**: 
  - ゲノム: `chr2:g.165389450C>G`
  - トランスクリプト: `NM_001040142.2:c.5644C>G`
  - タンパク質: `NP_001035232.1:p.Arg1882Gly`
- **遺伝子**: SCN2A
- **影響**: ミスセンス変異（1882番目のアルギニンがグリシンに置換）。
- **疾患関連**: 
  - **病原性 (P)**: **DEE11**、**BFIS3**、**発作性運動失調症9型**。
  - **未提供 (NP)**: **複雑な神経発達障害**。
- **予測モデル**:
  - **SIFT**: 0.0（有害）。
  - **AlphaMissense**: 0.8635（病原性の可能性が高い）。
- **対立遺伝子頻度**: gnomADで報告なし。
- **TogoVarリンク**: [TogoVar rs796053166](https://togovar.org/variant/2-165389450-C-G)

---

#### 3. 変異: C>T (rs796053166)
- **HGVS表記**: 
  - ゲノム: `chr2:g.165389450C>T`
  - トランスクリプト: `NM_001040142.2:c.5644C>T`
  - タンパク質: `NP_001035232.1:p.Arg1882Ter`
- **遺伝子**: SCN2A
- **影響**: ナンセンス変異（早期終止コドンを導入し、タンパク質が短縮）。
- **疾患関連**: 
  - **病原性 (P)**: **DEE11**。
  - **病原性の可能性が高い (LP)**: **先天性遺伝性疾患**。
- **対立遺伝子頻度**: gnomADで報告なし。
- **TogoVarリンク**: [TogoVar rs796053166](https://togovar.org/variant/2-165389450-C-T)

---

#### 類似した影響の要約
- **C>A**: 同義変異、ほぼ良性。
- **C>G**: ミスセンス変異、病原性、複数の神経疾患に関連。
- **C>T**: ナンセンス変異、病原性、重度の発達障害に関連。

SCN2A遺伝子の変異は、てんかんや神経発達障害において重要な役割を果たします。特にC>GおよびC>T変異は、臨床的に重要です。

#### 参考リンク
- TogoVar: [https://togovar.org](https://togovar.org)
- ClinVar: [VCV002116983](https://www.ncbi.nlm.nih.gov/clinvar/variation/2116983), [VCV000207028](https://www.ncbi.nlm.nih.gov/clinvar/variation/207028), [VCV000450533](https://www.ncbi.nlm.nih.gov/clinvar/variation/450533)